RPL39P38

Across TCGA pan-cancer cohorts, RPL39P38 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RPL39P38’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL39P38 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL39P38 is over-expressed in tumor, although a few such as UCEC and THCA show the opposite, repressed pattern.

KIRC, LIHC, and UCEC are the cancer types where RPL39P38 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL39P38 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	+0.545	<.001	9	view →
LIHC	Female	II,III,IV	+0.864	<.001	5	view →
UCEC	All	II,III,IV	−0.975	.043	4	view →
CHOL	All	All	+1.114	.004	2	view →
LUAD	All	All	+0.397	.008	2	view →
PRAD	All	All	+0.295	.021	2	view →
THCA	All	All	−0.286	.009	2	view →
BRCA	Female	All	−0.217	.020	2	view →
KICH	Female	II,III,IV	−0.531	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RPL39P38–KIRC

Open the KIRC breakdown →